Fi3 Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$958K Sell
7,078
-5,313
-43% -$139K 0.23% 47
2026
Q1
$348K Buy
12,391
+2,381
+24% +$63.4K 0.1% 120
2025
Q4
$249K Buy
10,010
+285
+3% +$7.19K 0.08% 151
2025
Q3
$248K Buy
9,725
+1,243
+15% +$30.7K 0.08% 123
2025
Q2
$206K Buy
8,482
+404
+5% +$9.42K 0.07% 161
2025
Q1
$205K Sell
8,078
-4,615
-36% -$121K 0.08% 127
2024
Q4
$337K Buy
+12,693
New +$344K 0.13% 67
2023
Q3
Sell
-5,512
Closed -$202K 77
2023
Q2
$202K Buy
+5,512
New +$215K 0.11% 65
2023
Q1
Sell
-5,290
Closed -$271K 81
2022
Q4
$271K Buy
+5,290
New +$254K 0.16% 49

Other funds holding PFE

Fi3 Financial Advisors's PFE Position: Q2 2026 in Review

Fi3 Financial Advisors reduced its Pfizer (PFE) stake by 43% in Q2 2026, selling an estimated $139K and leaving 7,078 shares worth $958K. The position accounts for 0.23% of the portfolio, ranked #47.

Fi3 Financial Advisors first reported a position in PFE in Q4 2022 and has held it in 9 quarters since. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fi3 Financial Advisors held 7,078 shares of Pfizer worth $958K as of Q2 2026.
  • Fi3 Financial Advisors sold 5,313 Pfizer shares in Q2 2026, an estimated $139K.
  • Pfizer made up 0.23% of Fi3 Financial Advisors's portfolio in Q2 2026, its #47 holding.
  • Fi3 Financial Advisors first reported a position in Pfizer in Q4 2022 and has held it in 9 quarters since.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fi3 Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.